Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
643 |
|
| Actual shortage: | 17 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 541 (84%) | |
Discontinuation Reports |
233 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 233 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
80 (9%) |
|
Overdue reports |
1 (6%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-10-03 | 2018-11-13 | 62963 |
| MYLAN-GALANTAMINE ER | 16MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-04-02 | 2020-05-12 | 110472 |
| MYLAN-GALANTAMINE ER | 16MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-06-30 | 2020-08-26 | 119216 |
| MYLAN-GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-05-01 | 2023-08-01 | 191317 |
| MYLAN-GALANTAMINE ER | 16MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-07-18 | 2024-03-25 | 198994 |
| MYLAN-GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-11-06 | 2024-03-25 | 209416 |
| MYLAN-FINGOLIMOD | 0.5 mg | capsules | Resolved | 2019-12-19 | 2020-03-13 | 101762 |
| MYLAN-CLOBETASOL CREAM | 0.05% | CREAM | Resolved | 2021-01-05 | 2021-07-21 | 130869 |
| MYLAN-CLOBETASOL CREAM | 0.05% | CREAM | Resolved | 2022-05-18 | 2022-05-25 | 160856 |
| MYLAN-CLOBETASOL CREAM | 0.05% | CREAM | Resolved | 2022-09-01 | 2023-02-06 | 168386 |
| MYLAN-CLOBETASOL CREAM | 0.05% | CREAM | Resolved | 2023-09-06 | 2023-12-19 | 203693 |
| MYLAN-CLOBETASOL CREAM | 0.05% | CREAM | Avoided shortage | 2024-01-30 | 2024-04-01 | 217870 |
| MYLAN-CLOBETASOL SCALP APPLICATION | 0.05% | LOTION | Resolved | 2017-08-10 | 2018-02-23 | 18684 |
| MYLAN-CLOBETASOL SCALP APPLICATION | 0.05% | LOTION | Resolved | 2020-08-13 | 2020-11-10 | 122091 |
| MYLAN-CLOBETASOL SCALP APPLICATION | 0.05% | LOTION | Resolved | 2022-11-17 | 2023-09-06 | 175112 |
| MYLAN-CLOBETASOL SCALP APPLICATION | 0.05% | LOTION | Resolved | 2023-09-06 | 2023-11-06 | 203708 |
| MYLAN-CLOBETASOL SCALP APPLICATION | 0.05% | LOTION | Actual shortage | 2024-01-30 | 2024-04-25 | 217873 |
| MYLAN-BECLO AQ | 50MCG | METERED-DOSE AEROSOL SUSPENSION | Resolved | 2017-06-28 | 2019-03-09 | 14271 |
| MYLAN-BECLO AQ | 50MCG | METERED-DOSE AEROSOL SUSPENSION | Resolved | 2019-03-15 | 2019-03-29 | 78777 |
| MYLAN-BECLO AQ | 50MCG | METERED-DOSE AEROSOL SUSPENSION | Resolved | 2019-04-03 | 2019-06-19 | 80428 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-07-10 | 2018-07-11 | 55141 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16009 |
| MYLAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16012 |
| MYLAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16015 |
| MYLAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16018 |
| MYLAN-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-06-06 | 2018-07-04 | 51653 |
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |